Glaukos Total Liabilities 2014-2024 | GKOS

Glaukos total liabilities from 2014 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Glaukos total liabilities for the quarter ending March 31, 2024 were $0.483B, a 3.99% increase year-over-year.
  • Glaukos total liabilities for 2023 were $0.479B, a 1.33% increase from 2022.
  • Glaukos total liabilities for 2022 were $0.472B, a 2.13% increase from 2021.
  • Glaukos total liabilities for 2021 were $0.463B, a 36.83% increase from 2020.
Glaukos Annual Total Liabilities
(Millions of US $)
2023 $479
2022 $472
2021 $463
2020 $338
2019 $145
2018 $33
2017 $28
2016 $17
2015 $21
2014 $30
2013 $24
Glaukos Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $483
2023-12-31 $479
2023-09-30 $471
2023-06-30 $468
2023-03-31 $464
2022-12-31 $472
2022-09-30 $460
2022-06-30 $469
2022-03-31 $455
2021-12-31 $463
2021-09-30 $463
2021-06-30 $459
2021-03-31 $433
2020-12-31 $338
2020-09-30 $333
2020-06-30 $333
2020-03-31 $138
2019-12-31 $145
2019-09-30 $117
2019-06-30 $114
2019-03-31 $43
2018-12-31 $33
2018-09-30 $27
2018-06-30 $23
2018-03-31 $20
2017-12-31 $28
2017-09-30 $21
2017-06-30 $20
2017-03-31 $15
2016-12-31 $17
2016-09-30 $19
2016-06-30 $19
2016-03-31 $18
2015-12-31 $21
2015-09-30 $23
2015-06-30 $33
2015-03-31 $33
2014-12-31 $30
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $24
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.184B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $208.577B 25.27
Intuitive Surgical (ISRG) United States $163.861B 92.78
Edwards Lifesciences (EW) United States $53.023B 34.51
Alcon (ALC) Switzerland $44.787B 32.08
IQVIA Holdings (IQV) United States $44.681B 25.33
DexCom (DXCM) United States $44.401B 67.26
IDEXX Laboratories (IDXX) United States $39.253B 46.01
STERIS (STE) Ireland $22.615B 26.42
Hologic (HOLX) United States $18.292B 20.47
Waters (WAT) United States $18.224B 26.78
SONOVA HOLDING (SONVY) Switzerland $17.878B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.502B 13.43
Teleflex (TFX) United States $10.485B 16.32
Sysmex ADR (SSMXY) Japan $10.241B 32.12
Globus Medical (GMED) United States $9.940B 29.14
Penumbra (PEN) United States $7.453B 84.69
Masimo (MASI) United States $5.714B 32.86
TransMedics (TMDX) United States $4.913B 466.16
Integer Holdings (ITGR) United States $4.328B 26.15
PROCEPT BioRobotics (PRCT) United States $3.553B 0.00
Inari Medical (NARI) United States $3.210B 0.00
LivaNova (LIVN) United Kingdom $2.938B 17.45
Tandem Diabetes Care (TNDM) United States $2.792B 0.00
Integra LifeSciences Holdings (IART) United States $2.485B 10.84
Veracyte (VCYT) United States $1.794B 0.00
RxSight (RXST) United States $1.754B 0.00
Alphatec Holdings (ATEC) United States $1.525B 0.00
Artivion (AORT) United States $1.146B 109.88
Silk Road Medical (SILK) United States $1.067B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.033B 20.10
Pulse Biosciences (PLSE) United States $1.030B 0.00
OPKO Health (OPK) United States $1.018B 0.00
OrthoPediatrics (KIDS) United States $0.789B 0.00
SiBone (SIBN) United States $0.693B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.602B 0.00
Mesa Laboratories (MLAB) United States $0.599B 17.73
IRadimed (IRMD) United States $0.584B 32.68
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Pacific Biosciences Of California (PACB) United States $0.490B 0.00
AxoGen (AXGN) United States $0.404B 0.00
Sight Sciences (SGHT) United States $0.397B 0.00
Nevro (NVRO) United States $0.349B 0.00
Tactile Systems Technology (TCMD) United States $0.301B 10.31
AngioDynamics (ANGO) United States $0.286B 0.00
Semler Scientific (SMLR) United States $0.242B 12.28
Delcath Systems (DCTH) United States $0.231B 0.00
NeuroPace (NPCE) United States $0.220B 0.00
Inogen (INGN) United States $0.217B 0.00
CVRx (CVRX) United States $0.212B 0.00
ClearPoint Neuro (CLPT) United States $0.198B 0.00
Accuray (ARAY) United States $0.194B 0.00
908 Devices (MASS) United States $0.191B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
EDAP TMS S.A (EDAP) France $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.144B 0.00
KORU Medical Systems (KRMD) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
Sensus Healthcare (SRTS) United States $0.106B 22.24
Hyperfine (HYPR) United States $0.085B 0.00
EnVVeno Medical (NVNO) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.072B 0.00
LENSAR (LNSR) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.060B 0.00
Neuronetics (STIM) United States $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Vicarious Surgical (RBOT) United States $0.044B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
NexGel (NXGL) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00